Braintree Drug Patent Portfolio
Braintree owns 3 orange book drugs protected by 3 US patents Given below is the list of Braintree's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10806743 | Method of administering lactitol to reduce plasma concentration of lactitol | 12 May, 2037 | Active |
| US7291324 | Method of bowel cleansing | 22 Oct, 2022 | Expired |
| US6930119 | Liquid pharmaceutical composition | 17 Jul, 2022 | Expired |
Latest Legal Activities on Braintree's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Braintree.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 03 Apr, 2024 | US10806743 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Jul, 2021 | US10806743 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Jul, 2021 | US7291324 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Jul, 2021 | US6930119 |
|
Correspondence Address Change
Critical
| 30 Jun, 2021 | US6930119 |
|
Correspondence Address Change
Critical
| 30 Jun, 2021 | US7291324 |
|
Correspondence Address Change
Critical
| 30 Jun, 2021 | US10806743 |
|
Application ready for PDX access by participating foreign offices
Critical
| 20 Oct, 2020 | US10806743 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Oct, 2020 | US10806743 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Oct, 2020 | US10806743 |
|
Email Notification
Critical
| 01 Oct, 2020 | US10806743 |
|
Issue Notification Mailed
Critical
| 30 Sep, 2020 | US10806743 |
| Mail O.P. Petition Decision | 22 Sep, 2020 | US10806743 |
|
Email Notification
Critical
| 22 Sep, 2020 | US10806743 |
| Mail-Petition Decision - Granted | 17 Sep, 2020 | US10806743 |
Braintree's Family Patents
Braintree Drug List
Given below is the complete list of Braintree's drugs and the patents protecting them.
1. Axid
Axid is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6930119 | Liquid pharmaceutical composition |
17 Jul, 2022
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Axid's drug page
2. Halflytely
Halflytely is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7291324 | Method of bowel cleansing |
22 Oct, 2022
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Halflytely's drug page
3. Pizensy
Pizensy is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10806743 | Method of administering lactitol to reduce plasma concentration of lactitol |
12 May, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pizensy's drug page